Baroness Sherlock (Lab)

My Lords, I am grateful to all noble Lords for their thoughtful contributions. Although we are having this debate in the Chamber rather than in Grand Committee, it is always good to have the opportunity to scrutinise things. The noble Baroness, Lady Grender, made an important point. These things should not go through without any consideration. They are too important for that, and the chance to have the conversation is welcome. The regulations introduce necessary changes to a highly technical set of regulatory regimes, but the changes preserve the high standards of protection we inherited from our time in the EU and ensure we can continue to recognise decisions made by the European Chemicals Agency, which remains highly respected. I will try to go through the points raised. I will not get to them all and I will have to write, for which I apologise. I will start with the list from the noble Baroness, Lady Bennett, as she tabled the amendment. First, the noble Baroness asked about adding the EU’s SVHCs to our list. The Government intend to make secondary legislation by June 2027, providing for the incorporation of the six EU hazard classes in GB CLP. The noble Baroness, Lady Grender, also asked about that. The work on developing that is already under way, and the HSE is currently engaging with stakeholders to understand the potential impacts of aligning with the EU on CLP measures, including its hazard classes. It has issued a stakeholder impact survey for exactly that purpose. The work has been progressed separately from the SI, as I explained, due to constraints in the REUL Act that prevent an overall increase in regulatory burdens. The Government have made it clear that reaching a negotiated SPS agreement with the EU is a key priority. Negotiations are ongoing but we are committed to reaching an agreement by the end of this year. Broadly, it is expected that the areas in scope will dynamically align with the relevant EU legislation. I hope that reassures noble Lords on that front. To be clear, we will continue engaging with the EU and other international partners at the UN GHS to consider the scientific basis for the six EU hazard classes. As the noble Baroness, Lady Bennett, knows, discussions at the UN GHS have not yet concluded, so the outcomes of those discussions have not been determined. The UK will take into account the EU’s intended action in response to the outcomes of the UN GHS work when formulating our own position on the conclusions of the UN GHS consideration. I underscore that we intend to make legislation by June 2027 that provides for the incorporation of the six EU hazard classes in GB CLP, and that is being done separately for reasons I have just explained. The noble Baronesses, Lady Stedman-Scott and Lady Bennett, raised questions about the resourcing of the HSE and its size. The HSE’s funding and its priorities and progress are monitored by the Government. DWP is the sponsor department for the HSE, and a delight it is. It is important work, much of which is at the centre of what we do. To be clear, the fundamental scientific judgments are not changing as part of our changing the regime here. The HSE’s business plan for this year confirms its continued commitment to concentrating on the most serious risks and to targeting industries with the greatest hazards and sectors with the worst risk management record. In response to the noble Baroness, Lady Stedman-Scott, I note that the HSE significantly increased its resources to deal with the extra workload after leaving the EU. For example, on 1 January 2021 there were 262 technical staff in the HSE’s chemicals regulation division, working across the six chemical supply and use regimes. Today that division has approximately 440 staff—so where it is necessary to respond, additional resource is put into those areas. The noble Baroness, Lady Bennett, raised the issue of the regulatory approach and the noble Lord, Lord Redwood, pulled it from the opposite direction. The HSE’s regulatory approach is aligned with the requirements of the growth duty, but its job is to achieve the right regulatory balance between supporting safe business practice and protecting workers and the public. Proportionate health and safety regulations facilitate economic growth, but the key is that they have to be proportionate. The noble Lord, Lord Redwood, is quite right. This is not about taking risks or cutting corners on safety; it is about making appropriate, proportionate decisions. There is no point in leaving regulatory requirements in place if they serve no purpose and do nothing to make anybody safer but simply make things more difficult for business. I should make a correction. Apparently, when I was talking about how biocides actually have a useful role in controlling harmful organisms, I said, “harmful organisations”. If I did, I was not dissing anyone’s organisation, just the organisms, so apologies for that. The noble Baroness, Lady Bennett, asked about the jurisdiction question. We can already consider a jurisdiction from anywhere—this is about speeding it up—but I reassure the noble Baroness that qualification for the fast-track evaluation process has to be subject to the criteria set out in the SI. The only jurisdiction that meets them now is the EU; no other jurisdiction adopts GHS in the same way as the UK, apart from the EU, and no other jurisdiction apart from the EU has an open and transparent classification system based on public consultation, as we do. Other jurisdictions can submit proposals, but they will be part of the normal-track evaluation process, and any proposals to add jurisdictions which are considered to meet the criteria will be included in the HSE work plan, subject to consultation as part of the work plan, and decisions are taken by Ministers. However, the bottom line is that they have to meet the criteria—that is the safety net. The noble Baroness, Lady Bennett, asked about removing the special reference identification number. She mentioned cutting red tape. Cutting red tape can sometimes be good. Special reference identification numbers are not a requirement of the Rotterdam convention. They were introduced for use in an EU IT system to which we no longer have any access, so they serve no useful purpose. Therefore, removing the requirement of the companies to obtain a special reference identification number for small quantities of chemicals being exported solely for research or analysis removes a completely unnecessary burden on businesses and on the HSE as the PIC-designated authority. They simply do not have a function. The noble Baroness asked about the disbanding of the Defra stakeholder event. Regular stakeholder engagement is really important in this area, as in others, but it can take many forms. I am advised that Defra will continue to engage closely with a range of stakeholders to gather their input, harness their expertise and share Defra’s thinking. It does not plan to organise any further CSF meetings but its engagement remains strong through its monthly chemicals NGO forum and the industry chemicals policy communication forum, as well as through relevant events. With regard to any HSE materials that were discussed in that context, I want to say really clearly that the HSE is happy to engage and consult with stakeholders at any time. If there are concerns about the HSE, I encourage the noble Baroness to get in touch with me and we can take that forward from there. The noble Lord, Lord Teverson, asked about the exceptional circumstances. Just to be clear, these reforms do not allow exceptional circumstances to be used to weaken protections. Divergence will occur only in exceptional circumstances and only on scientific and technical grounds, not on economic grounds. Government priorities explicitly emphasise maintaining high standards of health and environmental protection, and leaning into alignment with EU decisions unless scientifically justified otherwise. That could, for example, be the fact that more information may have come to light after an EU opinion had been issued, but it is scientific. I am assured that the HSE’s commitment to align with EU discussions has been welcomed across all chemical stakeholder groups—although, I acknowledge, possibly not by the noble Lord, Lord Redwood. That reflects a strong commitment across a number of priorities, including reducing trade barriers that arise from divergent standards, which will support trading goods with our biggest trading partner, and protecting the UK internal market by ensuring that different regulatory requirements do not apply in Northern Ireland, significantly reducing the risk of supplies of chemical products no longer supporting the market in Northern Ireland. I say to the noble Lord, Lord Redwood, that this process is not about banning other products in Northern Ireland. One of the things that closely aligning where possible does is to protect Northern Ireland’s supply chain by making sure that the company will still be able to supply and will want to supply. The extent of agreement or divergence with EU classification proposals or decisions will be identified and reported in the HSE work plan. I hope that answers the question he asked about that. I think somebody asked whether extending expiry dates would reduce risk protection. Just to be clear, these are substances that have previously been evaluated under the GB BPR, meaning that the risks are understood and they have already been approved for use. Postponing the expiry dates allows the HSE’s regulatory resources to be focused on higher priority evaluations, including first-time approvals where the risk is less well understood, and a limited number of high hazard renewals. I hope that makes a difference. It will mean that critical biocides remain on the GP market that in themselves would cause issues if they were not available. Nothing in the regulations allows new biocidal products which are not already on the market—rather, the purpose is continuity to ensure that essential products, such as those critical for aviation safety and safe drinking water, are not lost. The noble Baroness, Lady Stedman-Scott, raised the GB CLP notification database. In the absence of that, GB CLP suppliers can use other resources, such as the European Chemicals Agency’s analogous database, which may encourage agreement between EU and GB suppliers on hazard classifications of their chemicals, otherwise known as self-classifications. Duty holders also still have a legal obligation to self-classify. Substances that pose higher risks are already regulated under frameworks such as REACH, the GB BPR and the GB Plant Protection Products Regulations, or other downstream legislation such as the UK cosmetics regulation or the Control of Substances Hazardous to Health Regulations. This ensures ongoing oversight of relevant hazards and associated risks. I may be running out of things I can usefully say. I hope I have answered the things that are critical to today’s vote. I can assure the House that I will look carefully at Hansard and write to noble Lords with questions that I have not been able to answer. Although I am grateful for the scrutiny, I stand by the case I have set out for these regulations. This instrument is practical, proportionate and urgent. It keeps essential biocides available, safeguarding public health and critical infrastructure, while preserving the ability to respond quickly to emerging risks. It speeds up our regulatory decision-making so that it is more transparent and better targeted to GB needs, enabling us to align more quickly with EU classification decisions and prioritise chemical hazard evaluations of greatest importance to the GB market, and it simplifies export requirements under GB PIC while ensuring that we continue to meet our international obligations. These are measured improvements to ensure that the system works for Great Britain as intended, supports our chemicals industry, protects people and the environment, and allows the HSE to regulate where it delivers the greatest value. I hope that the noble Baroness, Lady Bennett, has been reassured and will not push her amendment to decline these regulations. If she does, I urge the House not to vote for it.